Sigma Genetics
Sigma Genetics is a biotechnology company that is building…
Seattle, United States · $125K raised
- Headquarters
- Seattle, Washington
- Employees
- 1–10
- Website
- sigmagenetics.com
- Total Funding
- $125K
- Last Round
- $125K SeedJan 2022
- Rounds
- 2
About
Sigma Genetics develops devices that can deliver DNA, RNA, and other charged molecules into cells by using magnetic fields. When compared to conventional electroporation, this technique has several key advantages, which include: the absence of arcing, the ability to scale, and the benefit of being non-invasive for in vivo applications. This platform technology can be applied to a wide range of applications- cell therapies, cancer drug delivery, DNA vaccines, biopharma manufacturing, and cosmetics.
Summary
Sigma Genetics is a Biotech company based in Seattle, United States. It has raised $125K in total across 2 rounds, most recently a $125K Seed round in Jan 2022. Investors include IKJ Capital and Y Combinator Continuity Fund.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company